N-substituted quinuclidinol esters as potential therapeutic antimuscarinic agents

Expert Opinion on Therapeutic Patents

Volumn 13, Issue 3, 2003, Pages 377-380

[No Author Info available]

Author keywords

Chronic obstructive pulmonary disease; Incontinence; Irritable bowel syndrome; Muscarinic antagonists; Muscarinic receptors; Quinuclidine

Indexed keywords

ACETIC ACID DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CLIDINIUM; ESTER DERIVATIVE; HETEROCYCLIC HYDROXY COMPOUND; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NITROGEN; PARA FLUOROHEXAHYDROSILADIFENIDOL; PHOSPHODIESTERASE IV INHIBITOR; PIRENZEPINE; QUATERNARY AMMONIUM DERIVATIVE; QUINUCLIDINOL DERIVATIVE; RECEPTOR SUBTYPE; STEROID; TOLTERODINE; UNCLASSIFIED DRUG; ZAMIFENACIN;

ALKYLATION; BLADDER MUSCLE; CHOLINERGIC STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ABSORPTION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; INTESTINE MUSCLE; IRRITABLE COLON; PATENT; RECEPTOR AFFINITY; RESPIRATORY SYSTEM; REVIEW; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; URINE INCONTINENCE;

EID: 0037350447     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/eotp.13.3.377.21336     Document Type: Review

References (15)

1. BROWN JH, TAYLOR P: Muscarinic receptor agonists and antagonists. In: The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE (Eds), McGraw Hill, New York (2001):155-173.
2. EGLEN RM, HEGDE SS WATSON N: Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. (1996) 48(4):531-565.
3. EHLERT FJ, THOMAS EA, GERSTIN EH, GRIFFIN MT: Muscarinic receptors and gastrointestinal smooth muscle. In: Muscarinic Receptor Subtypes in Smooth Muscle. Eglen RM (Ed.), CRC Press, Boca Raton (1997):92-147.
4. 3 muscarinic receptor in smooth muscle. In: Receptors and Channels. Kenakin T (Ed.), Harwood Academic Publishers (In Press).
5. 3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci. (1999) 64(6-7):387-394 (Published erratum appears in Life Sci. (1999) 64(26):2535).
6. CARMINE AA, BROGDEN RN: Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs (1985) 30-85-126.
7. HULME EC, BIRDSALL NJ BUCKLEY NJ: Muscarinic receptor subtypes. Ann. Rev. Pharmacol. Tavicol. (1990) 30:633-673.
8. EGLEN RM: Muscarinic receptor subtypes in smooth muscle. CRC Press, Boca Raton (1997).
9. EHLERT FJ, OSTROM RS, SAWYER GW: Subtypes of the muscarinic receptor in smooth muscle. Life Sci. (1997) 61(18):1729-1740.
10. 3 subtype. Proc. Natl. Acad. Sci. USA (2000) 97(17):9579-9584.
11. STENGEL PW, YAMADA M, WESS J, COHEN ML: M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2002) 282(5):R1443-R1449.
12. STENGEL PW, GOMEZA J, WESS J, COHEN ML: M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J. Pharmacol. Exp. Ther. (2000) 292(3):877-885.
13. 3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J. Neurosci. (2002) 22:10627-10632.
14. NEWGREEN DT NAYLOR A: Comparison of the functional muscarinic receptor selectivity of darifenacin with tolterodine and oxybutynin. Br. J. Pharmacol. (1996) 117:107P.
15. UNDEM BJ, LITCHTENSTEIN LM: Drugs used in the treatment of asthma. In: The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE (Eds), McGraw Hill, New York (2001):733-754.